Supercritical fluid and pharmaceutical applications. Part I: Process classification

The supercritical fluid technology has been target of many pharmaceuticals investigations in particles production for almost 35 years. This is due to the great advantages it offers over others technologies currently used for the same purpose. A brief history is presented, as well the classification of supercritical technology based on the role that the supercritical fluid (carbon dioxide) performs in the process.

Diseño y Desarrollo de Nuevas Entidades Químicas de Interés Farmacéutico. Design and Development of New Chemical Entities of Pharmaceutical Interest.

Este proyecto de investigación se basa fundamentalmente en diversas actividades concernientes a la investigación y desarrollo de nuevos fármacos. Estos estudios se llevan a cabo sobre nuevos derivados de las siguientes drogas líderes utilizadas en el tratamiento del SIDA: zidovudina (AZT), lamivudina (3TC), didanosina (ddI) y un tipo particular de Inhibidores No Nucleosídicos de la Transcriptasa Reversa (INNTR) conocidos como "diarilpirimidinas" (DAPYs). Se plantean para el presente proyecto los siguientes objetivos específicos:1. Diseño racional y síntesis de nuevos compuestos,2. Evaluación de actividades biológicas y citotoxicidad,3. Estudio de las propiedades fisicoquímicas de interés biológico y farmacéutico,4. Estudios farmacocinéticos y biofarmacéuticos.De esta manera, se ha considerado un estudio integrador, tendiente a conocer y entender el posible comportamiento en el organismo de nuevas entidades químicas de interés farmacéutico (NEQF). Así, nuestra hipótesis de trabajo se sustenta en que la variación de las propiedades fisicoquímicas y farmacocinéticas de las drogas actualmente en uso o en etapas de experimentación, podrá incidir favorablemente en la farmacoterapia del SIDA.Cabe destacar que la aplicación de diversos métodos computacionales, constituye una herramienta muy importante que se utilizada para cada uno de los objetivos planteados ya que brinda información complementaria y una ayuda invalorable para el diseño racional de drogas.Así, se diseñarán, prepararán y caracterizarán NEQF, estudiando en detalle sus propiedades moleculares. Se espera que la información generada represente una contribución para el desarrollo de nuevas opciones terapéuticas efectivas frente al agente causativo del SIDA, enfermedad para la cuál la opción de una terapia efectiva está lejos de ser la ideal.Como el proyecto se desarrolla dentro de un ámbito académico, las actividades previstas permitirán a los becarios y tesistas: 1) ampliar y profundizar los conocimientos teóricos relacionados con los temas de estudio; 2) desarrollar su capacidad creativa; 3) posibilitar el trabajo multidisciplinario. Es decir, se formarán recursos humanos altamente capacitados en el diseño y desarrollo de NEQF, finalizando las tesis doctorales en ejecución e incorporando nuevos jóvenes farmacéuticos.A partir de los resultados que se logren en el campo científico y académico, se espera contribuir a la promoción del conocimiento en el área del diseño y del desarrollo de Compuestos Farmacéuticos Activos. Es de nuestro especial interés que los resultados lleven a un posicionamiento del grupo en el área de la Química Medicinal, de la Bioorgánica y de la Biofarmacia.Con relación a la importancia del proyecto, cabe destacar que la Química Medicinal es una disciplina poco desarrollada en nuestro país, por lo tanto contribuirá no sólo a la generación de conocimiento en el área, sino también a la formación de recursos humanos. Cabe destacar la participación de jóvenes farmacéuticos que son los beneficiarios de dicho proceso de formación. Por otra parte, el desarrollo de NEQF conlleva en sí mismo un impacto social y económico importante, y redunda en beneficio de la salud de la población. Teniendo en cuenta la realidad actual, y considerando que la solución final para el tratamiento del SIDA aún no se ha alcanzado, optimizar la actividad/efectividad de fármacos conocidos y estudiar nuevas moléculas que actúen sobre diversas dianas biológicas constituye una esperanza para el tratamiento eficaz de esta enfermedad. Finalmente, teniendo en cuenta que la finalidad del proyecto es desarrollar nuevos agentes anti VIH con potencial aplicación clínica, es de esperar poder interaccionar con la industria farmacéutica y transferir los resultados a la misma.

Diseño y desarrollo de superficies modificadas. Aplicaciones ambientales, biomédicas y farmacéuticas. Design and development of modified surfaces. Environmental, biomedical and pharmaceutical applications.

El objetivo general de este proyecto de investigación es diseñar, desarrollar y optimizar superficies con propiedades especificas para ser utilizadas como sensores y biosensores, materiales biocompatibles, columnas para separaciones por electroforesis capilar, matrices para la liberación controlada de fármacos y sorbentes para remediación ambiental. Para concretar este objetivo, se propone específicamente modificar superficies o particulas apuntando a optimizar un sistema concreto relevante en aplicaciones farmaceuticas, ambientales o biomedicas: 1. Modificacion de arcillas naturales o sinteticas para desarrollar matrices portadoras de farmacos o sorbentes para remediacion ambiental:1.1 Estudiar ilitas modificadas con Fe(III) para maximizar las propiedades adsortivas frente a aniones contaminantes como arsenico. 1.2 Sintetizar LDH de Al y Mg modificados con compuestos de interés farmacéutico para diseñar sistemas de liberación controlada.2. Modificación de canales de chips y electrodos para optimizar la separación, detección y cuantificación de compuestos farmacéutico: 2.1 Diseñar y construir microchips para la separación por EC de compuestos de base fenólica.2.2 Evaluar polímeros que mejoren la respuesta y/o estabilidad de electrodos de Carbono para ser usados como detectores amperométrico de compuestos de base fenólica en sistemas FIA y miniaturizados de análisis integrados.3. Modificación de superficies sólidas con biomoléculas para el desarrollo y optimización de superficies de bio-reconocimiento:3.1 Evaluar el comportamiento de superficies de titanio modificadas con TiO2 y depósitos inorgánicos frente a la interacción con proteínas plasmáticas (PP) para el análisis de la biocompatibilidad superficial.3.2 Diseñar y desarrollar superficies biofuncionales para el reconocimiento especifico de D-aminoácidos, anticuerpos en pacientes chagásicos y simple hebra de ADN. Las técnicas que se emplearán para llevar a cabo el proyecto dependen del tipo de sistema de estudio. En particular los estudios correspondientes al objetivo 1 se realizarán mediante análisis químicos, térmico, DXR, SEM, IR, BET así como mediante titulaciones ácido-base potenciométricas, movilidades electroforéticas, cinética e isotermas de adsorción.En general para desarrollar el objetivo 2 se utilizarán técnicas electroquímicas clásicas para la caracterización de los electrodos, los que luego se utilizarán como detectores en un sistema FIA amperométrico, mientras que los microchips se emplearán en electroforesis capilar para la separación de diferentes compuestos de interés farmacéutico.Finalmente, el objetivo 3 se llevará a cabo por un lado modificando electrodos de titanio con distintos depósitos (electroquímicas, sol-gel, térmicas) de TiO2 e hidroxiapatita y evaluando la interacción con proteínas plasmáticas para analizar la biocompatibilidad de los materiales preparados. Por otro lado, se estudiará el proceso de adsorción-desorción de D-aminoácido oxidasa, antígenos del T. Cruzi y ADN de simple hebra para optmizar la capacidad de bio-reconocimiento superficial de D-aminoácidos, anticuerpos de chagásicos y de cadena complementaria de ADN. Para concretar este objetivo se utilizarán técnicas electroquímicas, espectroscópicas y microscopias.Debido al carácter multidisciplinario del presente proyecto de investigación, su ejecución se llevara a cabo a través de la colaboración de investigadores pertenecientes a distintas áreas de la Química y permitirá continuar con la formación de recursos humanos mediante la realización de tesis doctorales y estadías postdoctorales.

Resonancia Magnética Nuclear aplicada al estudio de nuevos sistemas farmacéuticos y biológicos, complejos poliméricos y conjuntos de espines modelo. Nuclear Magnetic Resonance applied to the study of new pharmaceutical and biological systems, polymeric complexes and model spin clusters.

El presente proyecto plantea utilizar integralmente la técnica de Resonancia Magnética Nuclear en sólidos como un medio experimental que permite entender fenómenos de la física fundamental, como así también realizar aplicaciones de interés en el campo de la química, los desarrollos farmacéuticos y la biología. Novedosas técnicas experimentales serán empleadas, en conjunción con otras más tradicionales, en la caracterización de nuevas estructuras poliméricas acomplejadas a metales, membranas biológicas y compuestos de interés farmacéutico en vías de desarrollo, los cuales presentan el fenómeno de polimorfismo . Esto se llevará a cabo complementando los resultados de RMN en sólidos con técnicas tanto espectroscópicas como analíticas (Infrarrojo, Difracción de Rayos X, Calorimetría, RMN en solución) y trabajo interdisciplinario. Paralelamente al desarrollo de estos temas, profundizaremos mediante investigación básica, en la compresión de la dinámica cuántica y el surgimiento de la irreversibilidad en sistemas de espines nucleares. Observaremos en particular la generación, evolución y control de las coherencias cuánticas múltiples en sistemas cuánticos abiertos, lo cual nos da información sobre tamaño de clusters de espines. Esto permitirá la correcta implementación de secuencias de pulsos sofisticadas, como así también desarrollar nuevos métodos de medición aplicados a la caracterización estructural y a la dinámica molecular de sólidos complejos. Debemos resaltar que este proyecto está conectado con aspectos tanto básicos como aplicados de la RMN en sólidos como técnica experimental, la cual se desarrolla en el país únicamente en FaMAF-UNC. Se nutre además de trabajo multidisciplinario promoviendo la colaboración con investigadores y becarios de distintas áreas (física, química, farmacia, biología) provenientes de distintos puntos del país. Finalmente podemos afirmar que este plan impulsa la aplicación de la física básica proyectada a diferentes áreas del conocimiento, en el ámbito de la provincia de Córdoba. The aim of the present proyect is to use Nuclear Magnetic Resonance (NMR) as a complete techique that allows the understanding of fundamental physics phenomena and, at the same time, it leads to important applications in the fields of chemistry, pharmaceutical developments and biology. New experiments will be used together with traditional ones, in the characterization of new metal-polymer complexes, biological membranes and pharmaceutical compounds, some of them presenting polymorfism. NMR experiments will be complemented with diverse spectroscopic and analytical techniques: Infrared, X ray Diffraction, Thermal Analysis, solution NMR, as well as multidisciplinary investigation. Additionally, the present proyect plans to study in depth several aspects of quantum dynamics phenomena and decoherence in nuclear spin systems. The present proyect is connected with basic and applied aspects of the solid state NMR technique, developed in our country, only at FaMAF-UNC. It is is composed by multidisciplinary work and it promotes the collaboration with researchers and students coming from different fields (physics, chemistry, pharmaceutical developments, biology) and different points of our country.

Training and development in Irish technology companies

The sustained economic growth that has been experienced in the Irish economy in recent years has relied, to a large extent, on the contribution and performance of those industry sectors that possess the ability to provide high-value-added products and services to domestic and international markets. One such contributor has been the Technology sector. However, the performance of this sector relies upon the availability of the necessary capabilities and competencies for Technology companies to remain competitive. The Expert Group on Future Skills Needs have forecasted future skills shortages in this sector. The purpose of this research has been to examine the extent to which Irish Technology companies are taking measures to meet changing skills requirements, through training and development interventions. Survey research methods (in the form of a mail questionnaire, supported by a Web-based questionnaire) have been used to collect information on the expenditure on, and approach to, training and development in these companies, in addition to the methods, techniques and tools/aids that are used to support the delivery of these activities. The contribution of Government intervention has also been examined. The conclusions have been varied. When the activities of the responding companies are considered in isolation, the picture to emerge is primarily positive. Although the expenditure on training and development is slightly lower than that indicated in previous studies, the results vary by company size. Technical employees are clearly the key focus of training provision, while Senior Managers and Directors, Clerical and Administrative staff and Manual workers are a great deal more neglected in training provision. Expenditure on, and use of, computer-based training methods is high, as is the use of most of the specified techniques for facilitating learning. However, when one considers the extent to which external support (in the form of Government interventions and cooperation with other companies and with education and training providers) is integrated into the overall training practices of these companies, significant gaps in practice are identified. The thesis concludes by providing a framework to guide future training and development practices in the Technology sector.

A study of the interaction between national and corporate culture in a selection of Irish based companies

This research studies the phenomenon of national and corporate culture. National culture is the culture the members of a country share and corporate culture is a subculture which members of an organisation share (Schein, 1992). The objective of this research is to reveal if the employees within equivalent Irish and American companies share the same corporate and national culture and to ascertain if, within each company, there is a link between national culture and corporate culture. The object of this study is achieved by replicating research which was conducted by Shing (1997) in Taiwan. Hypotheses and analytical tools developed by Shing are employed in the current study to allow comparison of results between Shing’s study and the current study. The methodology used, called for the measurement and comparison of national and corporate culture in two equivalent companies within the same industry. The two companies involved in this study are both located in Ireland and are of American and Irish origin. A sample of three hundred was selected and the response rate was 54%. The findings from this research are: (1) The two companies involved had different corporate cultures, (2) They had the same national culture, (3) There was no link between national culture and corporate culture within either company, (4) The findings were not similar to those of Shing (1997). The implication of these findings is that national and corporate culture are separate phenomena therefore corporate culture is not a response to national culture. The results of this research are not reflected in the finding’s of Shing (1997), therefore they are context specific. The core recommendation for management is that, corporate culture should take account of national culture. This is because although employees recognise the espoused values of corporate culture (Schein, 1992), they are at the same time influenced by a much stronger force, their national culture.

Motivating techniques within Irish and American manufacturing and service companies in the Northwest of Ireland

In today’s world, many companies are concentrating on both their technology and human resources to provide them with their competitive advantage. Hence, understanding what motivates people is particularly important for managers in order to develop and sustain a competitive edge. As a result, numerous theories have been advanced to help our understanding of the subject matter and from these theories many motivational methods have evolved to enhance motivation within the workplace. In addition, research has been conducted on the various types of motivational techniques utilised by companies within Ireland. However, very little research has been completed within specific geographical regions in Ireland concerning the types of motivational techniques implemented at different job levels and their impact on employees work performance. Thus the objective of this research was to identify the motivational techniques utilised at different job levels within large manufacturing and service companies in the Northwest of Ireland and examine how these techniques influence the performance levels of employees. Furthermore, the study examined if these companies have changed from traditional ways of motivating employees to newer techniques. The research methodologies used to undertake the research included interviews with the HR managers and questionnaires completed by different employees at various job levels within the participating companies. Overall the conclusions were varied. Many different types of motivation techniques were found within the study’s participating companies. Irish companies are improving their motivational techniques, however most of these techniques are only used within higher job levels. In contrast to their American counterparts, a variety of motivational techniques are utilised and implemented at all job levels. On a more positive note, the majority of these motivational techniques do increase performance levels at all job levels. From the extensive primary and secondary research conducted, the thesis concludes by offering a number of recommendations to assist companies in further development of their motivational techniques for all job levels. These recommendations hope to augment the success of companies through an enhanced motivated workforce.

IFRS adoption in Europe: the case of Germany

From 2005 onwards, consolidated financial statements of listed European companies will have to comply with IFRS (IAS). Many German companies began adopting those standards in the 1990s, on a voluntary basis, because of their need to access international capital funding. Spanish companies, by contrast, are not permitted to adopt IFRS before 2005. This paper has two purposes: first, it analyses the financial impact of initial IFRS adoption on the statement of changes in equity and the income statement of individual German companies. Second, and taking into account the German experience, it focuses on the expected impacts on a sample of listed Spanish companies in two industrial sectors: chemical-pharmaceutical and fashion. Our analysis of German companies comprised all non-financial DAX groups applying IFRS plus additional listed companies in the two selected industrial sectors identified above. The impact of initial adoption of IFRS on German companies was, both individually and overall, very significant. The analysis suggests that the expected impact on Spanish companies is likely to be significant but to a lesser degree than in respect of the German companies in the study.

Multimarket contact in pharmaceutical markets

The purpose of this paper is to analyze the effect of multimarket contact on the behavior of pharmaceutical firms controlling for different levels of regulatory constraints using IMS MIDAS database. Theoretically, firms that meet in several markets are expected to be capable of sustaining implicitly more profitable out- comes, even if perfect monitoring is not possible. Firms may find it profitable to redistribute their market power among markets where they are operating. We present evidence for nine OECD countries with different degrees of regulation and show that regulation affects the importance of economic forces on firms' price setting behavior. Furthermore, our results confirms the presence of the predictions of the multimarket theory for more market friendly countries (U.S. and Canada) and less regulated ones (U.K., Germany, Netherlands), in contrast, for highly regulated countries (Japan, France, Italy and Spain) the results are less clear with some countries being

Trials, tricks and transparency: how disclosure rules affect clinical knowledge

Scandals of selective reporting of clinical trial results by pharmaceutical firms have underlined the need for more transparency in clinical trials. We provide a theoretical framework which reproduces incentives for selective reporting and yields three key implications concerning regulation. First, a compulsory clinical trial registry complemented through a voluntary clinical trial results database can implement full transparency (the existence of all trials as well as their results is known). Second, full transparency comes at a price. It has a deterrence effect on the incentives to conduct clinical trials, as it reduces the firms'gains from trials. Third, in principle, a voluntary clinical trial results database without a compulsory registry is a superior regulatory tool; but we provide some qualified support for additional compulsory registries when medical decision-makers cannot anticipate correctly the drug companies' decisions whether to conduct trials. Keywords: pharmaceutical firms, strategic information transmission, clinical trials, registries, results databases, scientific knowledge JEL classification: D72, I18, L15

Seizures after single-agent overdose with pharmaceutical drugs: Analysis of cases reported to a poison center.

Abstract Context. Seizures during intoxications with pharmaceuticals are a well-known complication. However, only a few studies report on drugs commonly involved and calculate the seizure potential of these drugs. Objectives. To identify the pharmaceutical drugs most commonly associated with seizures after single-agent overdose, the seizure potential of these pharmaceuticals, the age-distribution of the cases with seizures and the ingested doses. Methods. A retrospective review of acute single-agent exposures to pharmaceuticals reported to the Swiss Toxicological Information Centre (STIC) between January 1997 and December 2010 was conducted. Exposures which resulted in at least one seizure were identified. The seizure potential of a pharmaceutical was calculated by dividing the number of cases with seizures by the number of all cases recorded with that pharmaceutical. Data were analyzed using descriptive statistics. Results. We identified 15,441 single-agent exposures. Seizures occurred in 313 cases. The most prevalent pharmaceuticals were mefenamic acid (51 of the 313 cases), citalopram (34), trimipramine (27), venlafaxine (23), tramadol (15), diphenhydramine (14), amitriptyline (12), carbamazepine (11), maprotiline (10), and quetiapine (10). Antidepressants were involved in 136 cases. Drugs with a high seizure potential were bupropion (31.6%, seizures in 6 of 19 cases, 95% CI: 15.4-50.0%), maprotiline (17.5%, 10/57, 95% CI: 9.8-29.4%), venlafaxine (13.7%, 23/168, 95% CI: 9.3-19.7%), citalopram (13.1%, 34/259, 95% CI: 9.5-17.8%), and mefenamic acid (10.9%, 51/470, 95% CI: 8.4-14.0%). In adolescents (15-19y/o) 23.9% (95% CI: 17.6-31.7%) of the cases involving mefenamic acid resulted in seizures, but only 5.7% (95% CI: 3.3-9.7%) in adults (≥ 20y/o; p < 0.001). For citalopram these numbers were 22.0% (95% CI: 12.8-35.2%) and 10.9% (95% CI: 7.1-16.4%), respectively (p = 0.058). The probability of seizures with mefenamic acid, citalopram, trimipramine, and venlafaxine increased as the ingested dose increased. Conclusions. Antidepressants were frequently associated with seizures in overdose, but other pharmaceuticals, as mefenamic acid, were also associated with seizures in a considerable number of cases. Bupropion was the pharmaceutical with the highest seizure potential even if overdose with bupropion was uncommon in our sample. Adolescents might be more susceptible to seizures after mefenamic acid overdose than adults. "Part of this work is already published as a conference abstract for the XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 27-30 May 2014, Brussels, Belgium." Abstract 8, Clin Toxicol 2014;52(4):298.

Pharmacokinetic profile of two different pharmaceutical forms of theophylline (a slow release tablet and a syrup) after multiple dose administration to healthy human volunteers

Due to the narrow therapeutic range of theophyline, plasma concentrations of this drug are monitored in patients undergoing chronic therapy. Slow-release preparations avoid the fluctuations in plasma levels and improve patient compliance. In this study, we have compared the pharmacokinetic profiles of a theophylline slow-release tablet and a syrup form, when administered in multiple doses to healthy adult volunteers. The classification based upon releasing patterns is confirmed.

Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring

OBJECTIVE: To reach a consensus on the clinical use of ambulatory blood pressure monitoring (ABPM). METHODS: A task force on the clinical use of ABPM wrote this overview in preparation for the Seventh International Consensus Conference (23-25 September 1999, Leuven, Belgium). This article was amended to account for opinions aired at the conference and to reflect the common ground reached in the discussions. POINTS OF CONSENSUS: The Riva Rocci/Korotkoff technique, although it is prone to error, is easy and cheap to perform and remains worldwide the standard procedure for measuring blood pressure. ABPM should be performed only with properly validated devices as an accessory to conventional measurement of blood pressure. Ambulatory recording of blood pressure requires considerable investment in equipment and training and its use for screening purposes cannot be recommended. ABPM is most useful for identifying patients with white-coat hypertension (WCH), also known as isolated clinic hypertension, which is arbitrarily defined as a clinic blood pressure of more than 140 mmHg systolic or 90 mmHg diastolic in a patient with daytime ambulatory blood pressure below 135 mmHg systolic and 85 mmHg diastolic. Some experts consider a daytime blood pressure below 130 mmHg systolic and 80 mmHg diastolic optimal. Whether WCH predisposes subjects to sustained hypertension remains debated. However, outcome is better correlated to the ambulatory blood pressure than it is to the conventional blood pressure. Antihypertensive drugs lower the clinic blood pressure in patients with WCH but not the ambulatory blood pressure, and also do not improve prognosis. Nevertheless, WCH should not be left unattended. If no previous cardiovascular complications are present, treatment could be limited to follow-up and hygienic measures, which should also account for risk factors other than hypertension. ABPM is superior to conventional measurement of blood pressure not only for selecting patients for antihypertensive drug treatment but also for assessing the effects both of non-pharmacological and of pharmacological therapy. The ambulatory blood pressure should be reduced by treatment to below the thresholds applied for diagnosing sustained hypertension. ABPM makes the diagnosis and treatment of nocturnal hypertension possible and is especially indicated for patients with borderline hypertension, the elderly, pregnant women, patients with treatment-resistant hypertension and patients with symptoms suggestive of hypotension. In centres with sufficient financial resources, ABPM could become part of the routine assessment of patients with clinic hypertension. For patients with WCH, it should be repeated at annual or 6-monthly intervals. Variation of blood pressure throughout the day can be monitored only by ABPM, but several advantages of the latter technique can also be obtained by self-measurement of blood pressure, a less expensive method that is probably better suited to primary practice and use in developing countries. CONCLUSIONS: ABPM or equivalent methods for tracing the white-coat effect should become part of the routine diagnostic and therapeutic procedures applied to treated and untreated patients with elevated clinic blood pressures. Results of long-term outcome trials should better establish the advantage of further integrating ABPM as an accessory to conventional sphygmomanometry into the routine care of hypertensive patients and should provide more definite information on the long-term cost-effectiveness. Because such trials are not likely to be funded by the pharmaceutical industry, governments and health insurance companies should take responsibility in this regard.